ArticleTrials2025

Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial.

Fangxiang Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.